Clinical Trial Update: Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer

View source ↗

Summary

A post-marketing surveillance study evaluating the safety and efficacy of exemestane (Aromasin) in patients with early or advanced breast cancer, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromasin (exemestane)

Snippet

Sponsor: Pfizer | Conditions: Breast Cancer | Status: COMPLETED | Results posted: 2015-06-09